You just read:

Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Market to hit $27 Billion by 2022, Despite Low Innovation - Research and Markets

News provided by

Research and Markets

06 Jan, 2017, 13:10 ET